Class Action Lawsuit Claims Abbott Knowingly Sold Defective FreeStyle Libre 3 Glucose Monitors
January 27, 2026 A class action lawsuit alleges Abbott knowingly sold FreeStyle Libre 3 sensors that provided falsely low glucose readings.
Lawsuit Filings
Class Action Lawsuit Claims Abbott Labs Illegally Requested Job Applicants’ Family Medical Histories
June 30, 2025 A class action lawsuit claims Abbott Labs violated the Illinois Genetic Information Privacy Act by requiring job applicants to disclose their family medical histories.
Similac Class Action Lawsuit Claims Certain Infant Formulas Contain Heavy Metals
March 24, 2025 A class action accuses Abbott Labs of failing to warn consumers that some of its Similac powdered infant formulas contain harmful levels of heavy metals.
Class Action Lawsuit Says Similac Go & Grow, Pure Bliss Toddler Drinks Are Not as Healthy as Advertised Due to Sugar Content
January 20, 2025 A class action claims Go & Grow and Pure Bliss Toddler Drinks by Similac faces are falsely advertised as healthy for children between 12 and 36 months.
Class Action Lawsuit Claims FreeStyle Libre Shares Website Users’ Private Info with Facebook, Google
September 17, 2024 Abbott Laboratories faces a class action over its alleged use of tracking tools on FreeStyle.Abbott.com that expose consumers’ private information.
Similac Lawsuit Says Go & Grow 360 Total Care Toddler Drink Labeled With Health Claims Prohibited by FDA
September 6, 2024 A class action alleges the labels of Similac Go & Grow 360 Total Care toddler drinks display nutrient content claims that are prohibited by the FDA.
PediaSure Grow & Gain Supplement Is Not ‘Clinically Proven’ to Help Kids Grow Taller, Class Action Says
May 17, 2023 A class action alleges PediaSure Grow & Gain is falsely advertised given that no evidence exists to support the claim that it is “clinically proven” to help increase a child’s height.
High-Sugar Ensure Nutrition Drinks Falsely Advertised as Healthy, Class Action Claims
October 19, 2022 Abbott Laboratories faces a class action that claims its Ensure-brand “Nutrition” drinks are misrepresented as healthy due to their high sugar content.
Popular Ovulation Test Kits Are Misleadingly Advertised, Class Action Alleges
September 14, 2022 Ovulation test makers faces a class action that alleges the companies have misleadingly advertised the accuracy of the products to capitalize on buyers’ “reproductive anxiety.”
Class Action Claims Similac Powder Formula Containers Don’t Make as Many Bottles as Advertised
July 7, 2022 A proposed class action claims that following the mixing instructions on containers of Similac Powder Formula will not yield as many bottles as advertised.
Similac Products Falsely Advertised as ‘Non-GMO,’ Class Action Alleges
March 31, 2022 A lawsuit claims certain Similac products are misleadingly labeled as “non-GMO” in that they contain ingredients derived from genetically modified food sources.
Baby Formula Recall: Similac, Alimentum, EleCare Maker Hit with Class Action Lawsuit
February 18, 2022 Abbott Laboratories faces a proposed class action in the wake of a voluntary recall of its Similac, Alimentum and EleCare powdered infant formulas.
Class Action Alleges Similac Pro-Advance Formula Falsely Advertised as Similar to Breast Milk
November 22, 2021 A class action alleges certain label claims touting Similac Pro-Advance infant formula as able to confer benefits the same as or similar to those of breast milk are false and misleading.
Lawsuit: Abbott Labs’ Similac Go & Grow Toddler Powder Labels 'Confusingly Similar’ to Nutritionally Different Infant Product
December 2, 2020 A class action alleges Abbott Labs has misleadingly labeled its Similac Go & Grow toddler drink in a manner that's "confusingly similar" to its infant formula.
Lawsuit Claims Pharma Companies Downplayed Risks of Opioid Use
December 7, 2017 Purdue Pharma, L.P., and three others have been named as defendants in a proposed class action that claims they misrepresented the efficacy and risks of using opioids for long-term and chronic pain management.
Lawsuit: Pharma Companies and Distributors Contributed to Opioid Crisis
November 16, 2017 Another proposed class action has been filed against various pharmaceutical companies and distributors, claiming the defendants’ deceptive marketing of opioid products has contributed to their widespread abuse.
Pharmaceutical Companies, Distributors Accused of Contributing to Widespread Opioid Abuse
November 16, 2017 A proposed class action has been filed against a group of pharmaceutical companies and distributors over claims that they deceptively marketed and sold opioids without fully disclosing their associated risks.